Study/year | Sample size | Gender (male/female) | Age | Country | Follow-up (month) | TEE follow-up (month) | CHADS2 | CHA2DS2-VASc | HAS-BLED | MINORS |
---|---|---|---|---|---|---|---|---|---|---|
Swaans 2012 [14] | 30 | 21/9 | 62.8 ± 8.5 | Netherlands | 12 | 6 | 2.5 | 3 | 2 | 19 |
Walker 2012 [15] | 26 | 20/6 | 63.0 ± 7.0 | Australia | 12 | 6 | 1.9 | 2.6 | - | 17 |
Swaans 2013 [16] | 10 | 5/5 | 61.6 ± 9.6 | Netherlands | 6 | 1.5 | 3 | 3.5 | 1.5 | 13 |
Alipour 2015 [8] | 62 | 40/22 | 64.0 ± 8.0 | Netherlands | 38 | 2 | 2.5 | 3.0 | 2 | 17 |
Calvo 2015 [7] | 35 | 25/10 | 70.0 ± 7.0 | Spain | 13 | 3 | 2.01 | 3.1 | 3.1 | 16 |
Romanov 2015 [17] | 45 | 28/17 | 60.0 ± 5.0 | Russia | 24 | 6 | - | 2.2 | 3.5 | 14 |
Phillips 2016 [9] | 98 | 67/31 | 65.0 ± 7.0 | Austrialia | 26.73 | 12 | 1.5 | 2.6 | 1.9 | 15 |
Fassini 2016 [10] | 35 | 28/35 | 72.0 ± 4.0 | Italy | 24 | 12 | - | 3 | 3 | 15 |
Panikker 2016 [18] | 20 | 13/7 | 68.0 ± 7.0 | United Kindom | 12 | 9 | - | 3.1 | 2.5 | 16 |
Pelissero 2017 [19] | 21 | 14/7 | 68.42 ± 10.61 | Italy | 14.93 | 14.93 | - | 2.8 | 3.2 | 15 |
Wintgens 2018 [13] | 349 | 202/147 | 63.1 ± 8.2 | Netherlands/Russia/Australia/Spain | 34.5 | 3 | 2.0 | 3.0 | 3.0 | 15 |
Phillips 2018 [20] | 139 | 76/139 | 64.1 ± 7.3 | Australia/Russia/Netherlands/Italy/USA/Malaysia | 1 | 1 | 2.2 | 3.4 | 1.5 | 17 |
Du 2018 [21] | 82 | 48/34 | 66.2 ± 8.4 | China | 11.2 | 6 | - | 4.4 | 3.5 | 18 |
Li 2020 [22] | 61 | 25/36 | 66.7 ± 9.2 | China | 24 | 12 | - | 4.2 | 3.4 | 19 |
Ren 2020 [23] | 76 | 47/29 | 67.0 ± 7.5 | China | 24 | 12 | - | 3.4 | 2.3 | 16 |
Mo 2020 [24] | 76 | 39/37 | 69.9 ± 7.9 | China | 24 | 6 | - | 3.6 | 3.3 | 18 |
Chen 2020 [25] | 178 | 94/84 | 68.9 ± 8.1 | China | 12 | 3 | - | 3.3 | 1.6 | 17 |
Ren 2020 [26] | 42 | 26/16 | 70.0 ± 7.6 | China | 20 | 12 | - | 3.8 | 3.7 | 17 |